Skip to main navigation Skip to search Skip to main content

A phase ll study of lenalidomide, ixazomib, dexamethazone, and daratumumab in transplant ineligible patients with newly diagnosed multiple myeloma

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date04/12/22 → 04/11/25

Funding

  • Alliance Foundation Trials LLC: $10,985.00